James Warren Huff, Chief Executive Officer at REATA PHARMACEUTICALS INC (RETA), sold 75,500 shares at $86.61 ($5.5M) on 2019-09-27, disclosed to the SEC on 2019-09-30.
Open-market sale of $5.5M RETA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 12,500 | $0 | 0.0% |
| 2 | $86.61 | 63,000 | $5.5M | 100.0% |
| Total | $72.27 avg | 75,500 | $5.5M | 100% |
| Filing → |
| RETA | BUY | 2016-06-02 | $1.3M | — | Filing → |